Current role of hepatopancreatoduodenectomy for the management of gallbladder cancer and extrahepatic cholangiocarcinoma: A systematic review

doi:10.4251/wjgo.v13.i6.625

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5116)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

419

WORD

142

HTML

3030

Figures (1-2)

338

Tables (1-3)

341

Sum=4270

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

398

Download

448

Sum=846

Jun 15, 2021 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Gastrointest Oncol. Jun 15, 2021; 13(6): 625-637
Published online Jun 15, 2021. doi: 10.4251/wjgo.v13.i6.625

Table 3 Studies reporting on survival outcomes after hepatopancreatoduodenectomy for gallbladder cancer and extrahepatic cholangiocarcinoma (2015-2020)

Ref.	Total n of patients	GC	ECC	Survival outcomes
Ref.	Total n of patients	GC	ECC	GC	ECC
Aoki et al[21], 2016	52	13	39	NR³	NR³
Lee et al[41], 2018	22	8	14	25.0%²	17.9%²
D’Souza et al[10], 2019	66	31	35	30.0%¹	80.0%¹
Toyoda et al[43], 2019	100	0	100	-	49.2%²
Liu et al[11], 2020	16	0	16	-	20.0%²
Shimizu et al[28], 2020	37	0	37	-	36.8%²

¹3-year overall survival.

²5-year overall survival.

³The study reported a 5-year survival of 44.5% for the entire cohort, with no significant difference between patients with gallbladder cancer and those with extrahepatic cholangiocarcinoma (P = 0.54).

GC: Gallbladder cancer; ECC: Extrahepatic cholangiocarcinoma; NR: Not reported.

Citation: Fancellu A, Sanna V, Deiana G, Ninniri C, Turilli D, Perra T, Porcu A. Current role of hepatopancreatoduodenectomy for the management of gallbladder cancer and extrahepatic cholangiocarcinoma: A systematic review. World J Gastrointest Oncol 2021; 13(6): 625-637
URL: https://www.wjgnet.com/1948-5204/full/v13/i6/625.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i6.625